Search company, investor...
Netrepid company logo

Netrepid

netrepid.com

Total Raised

$120K

Investors Count

2

Funding, Valuation & Revenue

2 Fundings

Netrepid's latest funding round was a Acquired for on August 3, 2021.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

8/3/2021

Acquired

0

FY undefined

2

9/20/2013

Seed

$99M

0

FY undefined

10

Date

8/3/2021

9/20/2013

Round

Acquired

Seed

Amount

$99M

Investors

Valuation

Revenue

0

FY undefined

0

FY undefined

Sources

2

10

This profile has not been claimed.

You're more than your latest funding, tell our customers your company's story.

Netrepid Investors

2 Investors

Netrepid has 2 investors. Tom Hogue invested in Netrepid's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/3/2021

8/3/2021

1
Acquired

Angel Investor (Individual)

Pennsylvania

00/00/0000

00/00/0000

Ben Franklin Technology Partners of Central & Northern PA

Subscribe to see more

Public-Private Partnership

Pennsylvania

First funding

8/3/2021

00/00/0000

Last Funding

8/3/2021

00/00/0000

Investor

Ben Franklin Technology Partners of Central & Northern PA

Rounds

1
Acquired

Subscribe to see more

Board Seats

Type

Angel Investor (Individual)

Public-Private Partnership

Location

Pennsylvania

Pennsylvania

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.